相似文献
1
Structural studies of a carbohydrate-containing immunoglobulin-lambda-light-chain amyloid-fibril protein (AL) of variable subgroup III.
Biochem J. 1986 Nov 1;239(3):545-51. doi: 10.1042/bj2390545.
2
The amino acid sequence of a carbohydrate-containing immunoglobulin-light-chain-type amyloid-fibril protein.
Biochem J. 1985 Nov 15;232(1):183-90. doi: 10.1042/bj2320183.
3
The amino-acid sequence of the variable region of a carbohydrate-containing amyloid fibril protein EPS (immunoglobulin light chain, type lambda).
Biol Chem Hoppe Seyler. 1985 Jul;366(7):617-25. doi: 10.1515/bchm3.1985.366.2.617.
4
The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR.
Biochem J. 1981 Jun 1;195(3):561-72. doi: 10.1042/bj1950561.
5
Amyloid fibrils derived from V-region together with C-region fragments from a lambda II-immunoglobulin light chain (HAR).
Biol Chem Hoppe Seyler. 1985 Sep;366(9):907-15. doi: 10.1515/bchm3.1985.366.2.907.
6
Localization of the carbohydrate units in a human immunoglobulin light chain, protein Sm lambda.
Eur J Biochem. 1981 Apr;115(3):643-52. doi: 10.1111/j.1432-1033.1981.tb06250.x.
7
Primary structure of a deleted human lambda type immunoglobulin light chain containing carbohydrate: protein Sm lambda.
Proc Natl Acad Sci U S A. 1975 Nov;72(11):4559-63. doi: 10.1073/pnas.72.11.4559.
8
The precursor molecule of a V lambda II-immunoglobulin light chain-derived amyloid fibril protein circulates precleaved.
Biochem Biophys Res Commun. 1993 Aug 16;194(3):1427-34. doi: 10.1006/bbrc.1993.1984.
9
Partial amino acid sequence of an amyloid fibril protein from nodular primary cutaneous amyloidosis showing homology to lambda immunoglobulin light chain of variable subgroup III (a lambda III).
J Invest Dermatol. 1990 Sep;95(3):301-3. doi: 10.1111/1523-1747.ep12484994.
10
The amino acid sequence of the glycosylated amyloid immunoglobulin light chain protein AL MS.
Scand J Immunol. 1997 May;45(5):551-6. doi: 10.1046/j.1365-3083.1997.d01-431.x.
引用本文的文献
1
Variable Domain -Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody Stability.
Front Immunol. 2018 Apr 12;9:740. doi: 10.3389/fimmu.2018.00740. eCollection 2018.
2
Fractionation of Fab glycosylated immunoglobulin G with concanavalin A chromatography unveils new structural properties of the molecule.
Oncotarget. 2016 May 24;7(21):31166-76. doi: 10.18632/oncotarget.9085.
3
Light chain amyloidosis - current findings and future prospects.
Curr Protein Pept Sci. 2009 Oct;10(5):500-508. doi: 10.2174/138920309789351949.
4
Variable domain-linked oligosaccharides of a human monoclonal IgG: structure and influence on antigen binding.
Biochem J. 1999 Mar 1;338 ( Pt 2)(Pt 2):529-38.
5
A role for destabilizing amino acid replacements in light-chain amyloidosis.
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5446-50. doi: 10.1073/pnas.91.12.5446.
6
Antibody variable region glycosylation: biochemical and clinical effects.
Springer Semin Immunopathol. 1993;15(2-3):259-73. doi: 10.1007/BF00201106.
7
The primary structure of the variable region of an immunoglobin IV light-chain amyloid-fibril protein (AL GIL).
Biochem J. 1988 Dec 15;256(3):973-80. doi: 10.1042/bj2560973.
8
Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.
J Clin Invest. 1991 Jun;87(6):2186-90. doi: 10.1172/JCI115252.
9
Complementary DNA sequence of human amyloidogenic immunoglobulin light-chain precursors.
Biochem J. 1992 Jul 1;285 ( Pt 1)(Pt 1):149-52. doi: 10.1042/bj2850149.
本文引用的文献
1
The major proteins of human and monkey amyloid substance: Common properties including unusual N-terminal amino acid sequences.
FEBS Lett. 1971 Dec 1;19(2):169-173. doi: 10.1016/0014-5793(71)80506-9.
2
Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).
N Engl J Med. 1980 Jun 12;302(24):1333-43. doi: 10.1056/NEJM198006123022403.
3
Primary structure of the variable part of an amyloidogenic Bence-Jones Protein (Mev.). An unusual insertion in the third hypervariable region of a human kappa-immunoglobulin light chain.
Hoppe Seylers Z Physiol Chem. 1982 Nov;363(11):1347-58. doi: 10.1515/bchm2.1982.363.2.1347.
4
Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda).
J Clin Invest. 1982 Aug;70(2):453-60. doi: 10.1172/jci110635.
5
The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR.
Biochem J. 1981 Jun 1;195(3):561-72. doi: 10.1042/bj1950561.
6
7
Amino acid sequences in amyloid proteins of kappa III immunoglobulin light-chain origin.
Scand J Immunol. 1983 Dec;18(6):557-60. doi: 10.1111/j.1365-3083.1983.tb00891.x.
8
Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).
N Engl J Med. 1980 Jun 5;302(23):1283-92. doi: 10.1056/NEJM198006053022305.
9
The characterization of soluble amyloid prepared in water.
J Clin Invest. 1968 Apr;47(4):924-33. doi: 10.1172/JCI105784.
10
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.
Zotero 插件